Cunningham Paul 🟡 adjusted position in 2.0K shares (1 derivative) of CADENCE DESIGN SYSTEMS INC (CDNS) at $323.32 Transaction Date: Aug 17, 2026 | Filing ID: 000093
Aurora Daljit Singh 🟡 adjusted position in 277.8K shares (11 derivative) of Neumora Therapeutics, Inc. (NMRA) at $1.65 Transaction Date: Aug 17, 2026 | Filing ID: 000362
📋 Averill Madison Master Fund, Ltd. (Affiliate) plans to sell 59K shares of Verademics, Inc. (at $107.25 each, total $6.4M) Filed: Aug 19, 2026 | ID: 000904
Director Peoples George 🟢 acquired 4.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039292
Emmerich Matthew J 🟡 adjusted position in 345 shares (1 derivative) of Ingersoll Rand Inc. (IR) at $82.31 Transaction Date: Aug 17, 2026 | Filing ID: 033770
Director Leftwich Scott 🟢 acquired 4.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039290
Director Stewart Alan R. 🟢 acquired 4.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039291
Jackson Andrew C. 🟢 acquired 14.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039289